Bexitrol HFA Inhaler is a metered-dose inhaler (MDI) manufactured by Beximco Pharmaceuticals Ltd., Bangladesh, and marketed in Nigeria by Standard Generics Limited. It contains Salbutamol Sulphate 100 mcg per metered dose, a short-acting beta-agonist (SABA) used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Indications
-
Asthma: For the relief of acute bronchospasm.
-
Chronic Obstructive Pulmonary Disease (COPD): For the relief of bronchospasm associated with COPD.
Dosage & Administration
-
Adults and Children (4 years and older):
-
Acute Bronchospasm: 1–2 puffs as needed; may repeat every 4–6 hours.
-
Exercise-Induced Bronchospasm: 2 puffs 15–30 minutes before exercise.
-
-
Administration:
-
Shake the inhaler well before each use.
-
Breathe out fully, then place the mouthpiece between your lips and inhale deeply while pressing down on the canister to release the medication.
-
Hold your breath for about 10 seconds, then exhale slowly.
-
If more than one puff is prescribed, wait about one minute before taking the second puff.
-
-
